A supercharged version of your muscle's natural repair signal—PEGylated Mechano Growth Factor stays active for days instead of minutes, waking up dormant stem cells to rebuild and strengthen damaged muscle tissue.
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Subcutaneous
Route
4 recommended
Sites
Twice weekly
Frequency
Preparation
Bacteriostatic water (BAC water)—the preservative keeps it safe for multiple uses
Insulin syringes (29-31 gauge)—thin needles mean less discomfort
Alcohol swabs for cleaning vial tops and injection sites
Your PEG-MGF powder vial
A clean, well-lit workspace
Pro tip
Prepare all supplies on a clean surface before you begin. Having everything ready makes the process smoother and more sterile.
Mixing
Wash your hands thoroughly with soap and water. Gather all supplies on a clean, flat surface.
Remove the plastic cap from the peptide vial and wipe the rubber stopper with an alcohol swab. Let it air dry.
Draw the appropriate amount of bacteriostatic water into a sterile syringe.
Insert the needle into the vial at an angle, aiming at the inside wall of the vial. Slowly push the plunger to let the water trickle down the glass wall -- do NOT squirt directly onto the powder.
Once all water is added, gently swirl the vial in a slow circular motion. Never shake the vial, as this can damage the peptide bonds.
Continue swirling until the powder is completely dissolved and the solution is clear. If particles remain, let the vial sit for a few minutes and swirl again.
Label the vial with the date of reconstitution, the peptide name, and the concentration (e.g. 250mcg per 0.1mL).
Example calculation
If you have a 2mg (2000 mcg) vial and add 2mL of BAC water, you get a concentration of 1000 mcg/mL. So every 0.1mL (10 units on an insulin syringe) equals 100 mcg of PEG-MGF.
Dose calculation
For a 200 mcg dose at 1000 mcg/mL concentration: draw 0.2mL (20 units on a standard insulin syringe). Always double-check your math before injecting.
Pro tip
Always add the bacteriostatic water slowly, letting it run down the side of the vial. Never shake the vial -- swirl gently to avoid damaging the peptide.
Location
Site 01
The specific muscle group you just trained (for targeted recovery)
Follow your provider's instructions for this injection site. Rotate sites regularly to prevent tissue damage.
Site 02
Abdomen
Pinch the skin 2 inches from navel. Avoid the area directly around the belly button. Rotate between left and right sides.
Site 03
Outer Thigh
Middle third of the outer thigh. Keep at least 4 inches above the knee and below the hip. Alternate legs each injection.
Site 04
Upper Arm
Back or outer area of the upper arm. This site may require assistance from another person for proper technique.
Rotate between 4 sites to prevent tissue buildup and ensure consistent absorption.
Pro tip
Rotate your injection sites with each dose to prevent lipohypertrophy (buildup of fatty tissue). Keep a simple log of where you last injected.
Step by step
Wash your hands thoroughly with soap and water
Clean the injection site with an alcohol swab and let it air dry
For subcutaneous: pinch about an inch of skin and insert at 45-degree angle
For intramuscular: insert needle straight (90 degrees) into the muscle belly
Push the plunger slowly and steadily—don't rush
Wait 5-10 seconds before removing the needle
Apply light pressure with a clean swab if needed—don't rub vigorously
Pro tip
This peptide uses subcutaneous or intramuscular injection—many users prefer intramuscular directly into the target muscle for localized effects. Inject at a 45-90 degree angle into pinched skin. Aspirate before injecting to ensure you haven't hit a blood vessel.
Timing
Optimal timing
Best time
Inject immediately after training the target muscle group. MGF is naturally released in response to muscle damage/stress, so post-workout timing mimics your body's natural repair process.
With food?
PEG-MGF can be taken regardless of food timing. However, avoid injecting within 30-60 minutes of eating a large meal if injecting intramuscularly, as blood flow changes may affect local distribution.
Stacking notes
If combining with IGF-1 LR3, use PEG-MGF immediately post-workout and IGF-1 LR3 on rest days or several hours later—they work through different but complementary pathways. Some protocols alternate them.
Sample daily schedule
Immediately post-workout
100-200 mcg injection
Site: Into the muscle group trained, or subcutaneous
Inject within 30 minutes of finishing your workout for best timing with natural MGF release. For bilateral muscles (legs, arms), can split dose between both sides.
Second weekly injection (48-72 hours after first)
100-200 mcg injection
Site: Same or different target muscle
Maintain consistent twice-weekly schedule. If not training that day, subcutaneous injection is fine. The extended half-life means you don't need daily dosing.
Dosing tiers
Dose
200 mcg
Frequency
2-3x per week, post-workout
Duration
5-6 week cycle
Lower end of reported community practice [6]. Important: PEG-MGF is a research peptide with no human clinical trials - all dosing is extrapolated from animal data and self-reported use, not established medicine [1][2]. Pegylation extends its half-life versus native MGF.
Dose
200-400 mcg
Frequency
2-3x per week, post-workout
Duration
5-6 week cycle, then time off
Typical reported research-use range, injected near the trained muscle or into abdominal fat shortly after training [6]. This is community practice, not a clinically validated dose; preclinical work shows MGF activates muscle satellite/progenitor cells [1][2].
Preservation
Before mixing
Keep your PEG-MGF powder refrigerated (36-46°F / 2-8°C) for short-term storage or frozen (-4°F / -20°C) for long-term storage. Protect from light and moisture. Properly stored powder remains stable for 2+ years when frozen, 6+ months refrigerated.
After mixing
Once mixed with bacteriostatic water, refrigerate at 36-46°F (2-8°C). Never freeze reconstituted peptide—freezing destroys it. Keep away from light and use within 3-4 weeks for best potency.
Shelf life after mixing
21-28 days
Signs of degradation
Discard the vial immediately if you notice any of these:
Cloudy or hazy appearance (should be crystal clear)
Visible particles floating or settled at the bottom
Color changes—any yellowing or discoloration means toss it
Unusual smell—fresh solution should have minimal odor
Important
When to stop
Any signs of allergic reaction—stop immediately and seek medical help
Injection site reactions that spread, worsen, or don't heal within 72 hours
Persistent headaches or fatigue that don't improve after the first week
Any blood sugar problems, especially if diabetic
Unusual lumps, growths, or tissue changes anywhere in your body
Your cycle is complete (4-8 weeks maximum)—always take at least 4 weeks off before re-dosing to prevent peptide desensitization and maintain IGF-1 pathway responsiveness
PEG-MGF is a research compound based on MGF (mechano growth factor), a naturally occurring IGF-1 splice variant, but the pegylated form is not FDA-approved. As a potent growth factor with extended half-life (48-72 hours vs. 5-7 minutes for unmodified MGF), it carries theoretical risks specific to sustained growth factor signaling. Cycling is essential to prevent receptor downregulation and potential off-target tissue growth. Never start, stop, or change your dosing without guidance from a qualified healthcare provider. This information is for educational purposes only—not medical advice. Individual responses can vary significantly based on age, training status, genetics, and overall health.
Clean technique checklist
Wash hands thoroughly with soap and water before handling supplies
Swab vial tops and injection site with alcohol and let dry
Never touch the needle tip or allow it to contact non-sterile surfaces
Use a new syringe and needle for each injection
Dispose of used sharps in a proper sharps container
Store reconstituted peptides according to the storage instructions above
Published research
Kandalla PK, Goldspink G, Butler-Browne G, Mouly V · 2011
This landmark study showed that the MGF E-peptide significantly increases the proliferative lifespan of satellite cells from young adults and delays their senescence. It boosted the cells' ability to fuse and repair muscle—exactly what you want for recovery. Importantly, researchers noted MGF could provide a new strategy against age-related muscle loss without the cancer risks of full IGF-1.
Hill M, Goldspink G · 2003
This foundational study from the lab that discovered MGF showed that after muscle damage, MGF is rapidly produced first and triggers satellite cell activation. Then the systemic IGF-1 form takes over to complete repair. This established the crucial 'first responder' role of MGF in muscle healing.
Doroudian G, Pinney J, Ayala P, et al. · 2014
Researchers showed that MGF peptide not only attracts stem cells to damaged areas but also protects heart muscle cells from dying under low-oxygen conditions. The MGF treatment increased stem cell migration and boosted the survival protein Bcl-2—demonstrating both the homing and protective effects of this peptide.
Deng M, Zhang B, Wang K, et al. · 2011
In a study that went beyond just muscle, researchers found that MGF E-peptide was actually more effective at stimulating bone-building cells than full IGF-1. Rabbits with bone defects healed significantly faster when treated with MGF. This opens doors for MGF in fracture healing and bone repair applications.
Hameed M, Orrell RW, Cobbold M, Goldspink G, Harridge SD · 2003
This human study revealed a critical age-related problem: after resistance exercise, young people showed a significant increase in MGF, but elderly subjects did not. This 'MGF deaf' response to exercise in older adults may explain age-related muscle loss—and suggests supplementing MGF could restore some youthful repair capacity.
Peptide Initiative · 2025
Summary of community/research-use dosing practice for PEG-MGF: approximately 200-400 mcg subcutaneously, 2-3 times per week, often timed post-workout, in ~5-6 week cycles. No human clinical trials exist; dosing is extrapolated from animal studies and self-reported practice.
Head to head